Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study

Philip D. Harvey, Hiroshi Nakamura, Sadanori Miura

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study'. Together they form a unique fingerprint.

Medicine & Life Sciences